PHG : Summary for Koninklijke Philips N.V. NY Reg - Yahoo Finance

U.S. Markets closed

Koninklijke Philips N.V. (PHG)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
29.73+0.11 (+0.37%)
At close: 4:02 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close29.62
Bid29.73 x 2800
Ask29.74 x 9800
Day's Range29.25 - 29.74
52 Week Range23.00 - 30.61
Avg. Volume1,317,626
Market Cap27.67B
PE Ratio (TTM)33.71
Earnings DateN/A
Dividend & Yield0.90 (3.04%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Philips Partners with NYMC to Boost Healthcare Portfolio
    Zacks2 days ago

    Philips Partners with NYMC to Boost Healthcare Portfolio

    Koninklijke Philips NV (PHG) recently strengthened its collaboration with premier academic institution, New York Medical College (NYMC), for co-creation of its digitally advanced oncology genomics solution, Philips IntelliSpace.

  • Is Manulife Financial Corporation (USA) (MFC) A Good Stock To Buy?
    Insider Monkey3 days ago

    Is Manulife Financial Corporation (USA) (MFC) A Good Stock To Buy?

    Does Manulife Financial Corporation (USA) (NYSE:MFC) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund sentiment towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions […]

  • Reuters3 days ago

    From smart toothbrushes to cancer, Philips bets big on software

    These days the average researcher at Philips (PHG.AS) is more likely to be a software developer than an product engineer, reflecting a transformation at the former Dutch conglomerate that its chief executive says will gather pace. "It's a huge shift," Frans van Houten told Reuters, noting that around 60 percent of the healthcare technology company's R&D staff are now focused on software. Philips has repositioned itself as a health business after spinning off lighting, which has freed up capacity for acquisitions such as last year's $1.2 billion purchase of blood vessel imaging firm Volcano.